Correlation Between Ubisoft Entertainment and Conduit Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Ubisoft Entertainment and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ubisoft Entertainment and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ubisoft Entertainment and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Ubisoft Entertainment and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ubisoft Entertainment with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ubisoft Entertainment and Conduit Pharmaceuticals.

Diversification Opportunities for Ubisoft Entertainment and Conduit Pharmaceuticals

0.13

Correlation Coefficient

Ubisoft Entertainment  Conduit Pharmaceuticals

Average diversification

The 3 months correlation between Ubisoft and Conduit is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Ubisoft Entertainment and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Ubisoft Entertainment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ubisoft Entertainment are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Ubisoft Entertainment i.e., Ubisoft Entertainment and Conduit Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ubisoft Entertainment and Conduit Pharmaceuticals

Assuming the 90 days horizon Ubisoft Entertainment is expected to generate 0.21 times more return on investment than Conduit Pharmaceuticals. However, Ubisoft Entertainment is 4.77 times less risky than Conduit Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest  1,300  in Ubisoft Entertainment on December 20, 2024 and sell it today you would earn a total of  70.00  from holding Ubisoft Entertainment or generate 5.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ubisoft Entertainment  vs.  Conduit Pharmaceuticals

Ubisoft Entertainment

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Ubisoft Entertainment are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Ubisoft Entertainment may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Conduit Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Conduit Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Ubisoft Entertainment and Conduit Pharmaceuticals

The main advantage of trading using opposite Ubisoft Entertainment and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ubisoft Entertainment position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.

The idea behind Ubisoft Entertainment and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..